Sheng Sheng Biology
Series A in 2024
Sheng Sheng Biology is a biotechnology company that provides medical research and experimental development services.
Leman Biotech
Series A in 2024
Leman Biotech is a developer and researcher of novel tumor immunotherapy drugs. The company focuses on therapies that leverage immunometabolic reprogramming and artificial intelligence. It has pioneered the Meta 10 immune metabolism reprogramming technology and built a platform for discovering, developing, and producing biological macromolecular drugs and new immune cell therapies.
Leman Biotech
Seed Round in 2024
Leman Biotech is a developer and researcher of novel tumor immunotherapy drugs. The company focuses on therapies that leverage immunometabolic reprogramming and artificial intelligence. It has pioneered the Meta 10 immune metabolism reprogramming technology and built a platform for discovering, developing, and producing biological macromolecular drugs and new immune cell therapies.
Novamab is a biotechnology company specializing in the development of novel nanobodies, a type of single-domain antibody with unique therapeutic advantages. With over 15 years of experience in nanobody research and development, the company's team of pioneers in this field has established platforms to maximize the potential of nanobodies. Novamab focuses on creating innovative drug formulations such as inhaled macromolecular drugs, albumin nanobody long-acting therapies, and nanobody double-antibody combinations. Their primary goal is to address unmet clinical needs by improving administration methods and reducing treatment cycles for major chronic diseases like cancer, autoimmune disorders, and cardiovascular conditions.
Hengsai Biological
Series A in 2023
Hengsai Bio is a tumor immunotherapy developer that engages in R&D and industrialisation of a new generation dendritic cell tumor vaccines.
Euregen Biopharma
Seed Round in 2023
Euregen Biopharma is a pharmaceutical company that specializes in the innovation and development of synthetic lethal drugs for tumors.
Mainstream Biotech
Series A in 2022
Mainstream Bio is a biotechnology company grounded in research, specializing in the development of innovative peptide therapeutics 2.0.
Intellective Bio
Series C in 2022
Intellective Bio is a contract development and manufacturing organization specializing in biopharmaceutical solutions, particularly in the areas of monoclonal antibodies and antibody-drug conjugates. The company offers comprehensive services that encompass the entire biopharmaceutical development and production process. It is equipped with advanced technical platforms, including protein science, cell engineering, cell culture, protein purification, analytical science, and formulation development. Intellective Bio also operates a pilot plant and a GMP workshop, featuring capabilities for aseptic preparation, filling, and freeze-drying production. This extensive infrastructure enables the company to provide clients with integrated solutions tailored to their specific biopharmaceutical needs.
DoyCan
Angel Round in 2022
DoYCan is focused on creating an Internet rehabilitation hospital platform aimed at improving the management of rehabilitation for stroke patients. The company has developed a Software as a Service (SaaS) platform that integrates telerehabilitation, facilitating comprehensive rehabilitation management through a three-level network system. This system encompasses three-level hospitals, community health service stations, and family support, allowing for a seamless blend of in-hospital and out-of-hospital rehabilitation services. By leveraging digital medical care and sports rehabilitation techniques, DoYCan provides effective solutions for patients with mobility challenges, ensuring they receive the necessary support throughout their recovery journey.
Resproly specializes in the research, development, production, and sales of respiratory inhalation formulas and equipment. The company focuses on clinically demanding treatment areas such as asthma, COPD (Chronic Obstructive Pulmonary Disease), diabetes, and Parkinson's disease.
Xinling Pharmaceutical
Seed Round in 2022
Xinling Pharmaceutical is a formulation technology developer for the transdermal patch and oral film. They develops transdermal patch and oral film drug products with lower toxicity, higher efficacy, and better patient compliance over other dosage forms.
Novamab is a biotechnology company specializing in the development of novel nanobodies, a type of single-domain antibody with unique therapeutic advantages. With over 15 years of experience in nanobody research and development, the company's team of pioneers in this field has established platforms to maximize the potential of nanobodies. Novamab focuses on creating innovative drug formulations such as inhaled macromolecular drugs, albumin nanobody long-acting therapies, and nanobody double-antibody combinations. Their primary goal is to address unmet clinical needs by improving administration methods and reducing treatment cycles for major chronic diseases like cancer, autoimmune disorders, and cardiovascular conditions.
Qingmi Keji is a company which is based in the electric circuit information industry, with integrated circuits, intelligent control, signal transmission, and control as the development direction and is committed to the design, development, and prosuction of home products. The interface supports market-leading brand electronic products and is compatible with a dedicated IC. Electronic equipment can be properly protected and potential safety risks can be avoided using overcurrent, overvoltage, short circuit, and protection features.
TXCE specializes in software and hardware development, system integration, and technical services within the communications sector, particularly for rail transportation. The company designs and provides advanced equipment and systems, including integrated wireless communication systems for locomotives, emergency communication systems, integrated video surveillance systems, and traffic management communication systems. TXCE is committed to delivering comprehensive communication solutions tailored to the needs of industry users. In addition to its product offerings, the company maintains various management systems, including quality management, environmental management, occupational health and safety management, information security management, and information technology service management, ensuring high standards across its operations.
enzd is a communication protocol for intelligent lighting control systems. They manufacture sensors for smart home applications such as controlling lights, making brightness adjustments, and making real-time monitoring calls for help. They promote energy efficiency management and have supported multiple office spaces.
Qingmi Keji
Series A in 2015
Qingmi Keji is a company which is based in the electric circuit information industry, with integrated circuits, intelligent control, signal transmission, and control as the development direction and is committed to the design, development, and prosuction of home products. The interface supports market-leading brand electronic products and is compatible with a dedicated IC. Electronic equipment can be properly protected and potential safety risks can be avoided using overcurrent, overvoltage, short circuit, and protection features.
Qingmi Keji
Angel Round in 2015
Qingmi Keji is a company which is based in the electric circuit information industry, with integrated circuits, intelligent control, signal transmission, and control as the development direction and is committed to the design, development, and prosuction of home products. The interface supports market-leading brand electronic products and is compatible with a dedicated IC. Electronic equipment can be properly protected and potential safety risks can be avoided using overcurrent, overvoltage, short circuit, and protection features.
PASSMEDIA
Series A in 2015
PASSMEDIA design of animation derivative products, investment in film and television dramas, production of TV programs, creation and production of film and television dramas. It is a media company that provides animation and gaming services.
Phenom Films
Angel Round in 2015
Phenom Films provides one-stop professional production services for the film and television cultural markets. It also offers visual effect scheme design, visual special effect production, virtual shooting, digital intermediate film color correction, sound production, full film editing, DIT data management, trailer creation, empty mirror material agency, and other services.
Infinitas Interactive Media
Series A in 2015
Infinitas Interactive Media provides big data and Internet advertising services.
Zilin Vinegar Industry is a brewing industry with microbial fermentation as its core technology, and an enterprise in agricultural industrialization vinegar brewing industry. Their product includes vinegar, fruit vinegar, vinegar drink, cooking wine, soy sauce, soybean paste, sesame oil, tahini, health vinegar, and gift vinegar.
Ying Feng
Angel Round in 2012
Ying Feng is a seafood processing company.
Aigo is involved in the production and supply of electronic products for their consumers. Their product line consists of storage, Internet terminals, audio, digital recording, security, smart energy, smart hardware, smart homes, and other fields.
Sanroad is committed to innovating vaccines and benefiting human health by integrating research and development, production, and sales of preventive biological products, biological drugs, chemical drugs, in vivo and in vitro diagnostic reagents and building a service provider of integrated solutions in the field of tuberculosis.
Ningxia Tairui Pharmaceutical Co., Ltd. is a biopharmaceutical company located in Yinchuan, China, specializing in the research, development, production, and sale of active pharmaceutical ingredients and formulations. Founded in 2000, the company offers a range of products including tylosin, used for the clinical treatment and prevention of mycoplasma infections; tilmicosin, which targets pleuropneumoniae and other bacterial infections; tiamulin fumarate, effective in preventing and treating swine diarrhea, pneumonia, and arthritis; and erythromycin thiocyanate, a macrolide antibiotic used for respiratory diseases. Tairui's focus is on providing high-quality raw materials, premixes, and feed additives for the pharmaceutical and agricultural sectors.
Aigo is involved in the production and supply of electronic products for their consumers. Their product line consists of storage, Internet terminals, audio, digital recording, security, smart energy, smart hardware, smart homes, and other fields.
Hefei Metalforming Intelligent Manufacturing
Private Equity Round in 2009
Hefei Metalforming Intelligent Manufacturing produces a range of metal forming equipment, including deep drawing presses, metal stamping presses, double action presses, blanking presses, molding presses, dishing presses, die spotting presses, tryout presses, open die forging presses, close die forging presses, isothermal forging presses, and ring rolling machines.
Recomgen Biotech
Angel Round in 2000
Recomgen Biotech is an innovative biopharmaceutical company that focuses on large-scale serum-free continuous animal cell culture technology and the R&D of new biological drugs. Recomgen Biotech is working on developing rhTNK-tPA, a generation-specific thrombolytic drug that can be injected intravenously in a single dose, making it convenient for emergency treatment and out-of-hospital thrombolysis as needed. It improves the treatment rate, clinical benefit, and personal and societal medical burdens in patients with acute myocardial infarction who received thrombolytic therapy.